$4.37
0.91% day before yesterday
Nasdaq, Feb 21, 10:00 pm CET
ISIN
US7163821066
Symbol
PETS

PetMed Express, Inc. Stock price

$4.37
-0.80 15.47% 1M
+1.28 41.42% 6M
-0.45 9.34% YTD
-0.76 14.81% 1Y
-21.60 83.17% 3Y
-24.13 84.67% 5Y
-11.01 71.59% 10Y
Nasdaq, Closing price Fri, Feb 21 2025
-0.04 0.91%
ISIN
US7163821066
Symbol
PETS
Industry

Key metrics

Market capitalization $90.27m
Enterprise Value $41.29m
P/E (TTM) P/E ratio 408.41
EV/FCF (TTM) EV/FCF 48.01
EV/Sales (TTM) EV/Sales 0.17
P/S ratio (TTM) P/S ratio 0.37
P/B ratio (TTM) P/B ratio 0.94
Dividend yield 27.46%
Last dividend (FY23) $1.20
Revenue growth (TTM) Revenue growth -10.82%
Revenue (TTM) Revenue $247.01m
EBIT (operating result TTM) EBIT $580.00k
Free Cash Flow (TTM) Free Cash Flow $860.00k
Cash position $50.10m
EPS (TTM) EPS $0.01
P/S forward 0.39
EV/Sales forward 0.18
Short interest 6.25%
Show more

Is PetMed Express, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,815 stocks worldwide.

PetMed Express, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a PetMed Express, Inc. forecast:

1x Hold
50%
1x Sell
50%

Analyst Opinions

2 Analysts have issued a PetMed Express, Inc. forecast:

Hold
50%
Sell
50%

Financial data from PetMed Express, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
247 247
11% 11%
100%
- Direct Costs 186 186
9% 9%
75%
62 62
15% 15%
25%
- Selling and Administrative Expenses 54 54
29% 29%
22%
- Research and Development Expense - -
-
-
7.44 7.44
287% 287%
3%
- Depreciation and Amortization 6.86 6.86
11% 11%
3%
EBIT (Operating Income) EBIT 0.58 0.58
106% 106%
0%
Net Profit 0.36 0.36
105% 105%
0%

In millions USD.

Don't miss a Thing! We will send you all news about PetMed Express, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetMed Express, Inc. Stock News

Neutral
Seeking Alpha
12 days ago
PetMed Express, Inc. (NASDAQ:PETS ) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Reed Anderson - IR, ICR Sandra Campos - CEO and President Robyn D'Elia - CFO Conference Call Participants Erin Wright - Morgan Stanley Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express Third Quarter Financial Results Conference Call. At ...
Positive
Seeking Alpha
13 days ago
PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-ter...
Neutral
GlobeNewsWire
3 months ago
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the “Rights Plan”).
More PetMed Express, Inc. News

Company Profile

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Head office United States
CEO Sandra Campos
Employees 287
Founded 1996
Website www.1800petmeds.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today